• Held 2025 CEO Investor Day on 27^th presenting its future growth strategy based on its “New Vision” of leading the mobility paradigm.
• Emphasized its strategy to lead the market with leading technologies such as windshield displays, SDV solutions, and BSA, which completely blocks heat transfer
• Planning to strengthen its independent capabilities in automotive semiconductors(systems/power) and pursue entry into the actuator market, a core component in the robotics field.
• Operating a profit and loss management system at all stages from product development to mass production expanding orders in high-growth emerging markets such as China and India.

SEOUL, South Korea, Aug. 27, 2025 /PRNewswire/ — Hyundai Mobis held its 2025 CEO Investor Day on August 27, bringing together investors, analysts, and credit rating agencies to present its long-term growth strategy under the new vision of leading the future mobility paradigm. President and CEO Lee Gyu-suk outlined strategic directions focused on three pillars: strengthening technology competitiveness, improving profitability, and expanding its global customer base.

• Hyundai Mobis is currently building a lineup of leading-edge technologies, including windshield displays and SDV solutions.

The company is currently concentrating on advanced technologies in key future mobility areas—electrification, electronics, semiconductors, and robotics. A standout innovation is its next-generation windshield display, which uses holographic optical film to transform the windshield into a transparent screen. First unveiled at CES 2025, this technology is being co-developed with German optics firm ZEISS and is expected to launch around 2029.

In the software-defined vehicle(SDV) sector, Hyundai Mobis is developing a standardized platform based on its advanced E/E architecture, enabling software-based control across various vehicle types. Full-scale commercialization is targeted after 2028, following platform development and vehicle demonstrations.

In electrification, the company is enhancing battery safety with systems that block heat transfer between cells using fire-resistant materials, and an automatic fire suppression system that activates upon ignition. These innovations aim to improve customer experience and reinforce Hyundai Mobis’ leadership in future mobility technologies.

• Hyundai Mobis plans to actively promote its automotive semiconductor and robotics business, “We will seize future growth opportunities.”

Hyundai Mobis also announced plans to strengthen its competitiveness in next-generation automotive semiconductors and robotics. In semiconductors, it is pursuing a two-track strategy: system semiconductors and power semiconductors. The company is developing Communication SoCs and Battery Monitoring ICs, while accelerating in-house mass production of power semiconductors—critical components for EV drive systems.

To date, Hyundai Mobis has developed 16 types of semiconductors and plans to produce 20 million units this year. Its R&D process has earned the highest ISO 26262 safety rating, and it is currently developing 11 next-generation chips. The company is also working to build a domestic semiconductor ecosystem through partnerships with automakers, fabless firms, and foundries, and will host a dedicated forum next month.

In robotics, Hyundai Mobis announced its entry into the actuator market, leveraging its expertise in vehicle steering systems. Actuators, which control robot movement, share core components with electronic steering systems and account for over 60% of humanoid robot production costs. Starting with actuators, the company plans to expand into sensors and controllers.

• Hyundai Mobis plans to actively promote its automotive semiconductor and robotics business, “We will seize future growth opportunities.”

To support sustainable growth, Hyundai Mobis is restructuring its business portfolio with a focus on profitability. It aims to achieve over 8% annual sales growth and a 5–6% operating profit margin by 2027 through product specialization and resource reallocation toward future core technologies. The company is currently evaluating the competitiveness of around 60 products and enhancing its profit management system across all stages—from development to mass production.

Hyundai Mobis also plans to strengthen its global presence by increasing the share of global customers in core parts sales to 40% by 2033. It will deepen partnerships in North America and Europe and expand orders in high-growth markets like China and India through localized product strategies and supply chain reinforcement.

Lastly, the company reaffirmed its commitment to maximizing shareholder value. This year, Hyundai Mobis repurchased and canceled treasury shares worth 620 billion won—nearly four times last year’s amount—demonstrating its dedication to transparent and predictable shareholder return policies, including dividends and buybacks. Hyundai Mobis will continue to actively implement its transparent and predictable shareholder return policy based on trust with its shareholders.

About Hyundai Mobis

Hyundai Mobis is the global no. 6 automotive supplier, headquartered in Korea. It has outstanding expertise in sensors, sensor fusion in ECUs and software development for safety control. The company’s products also include various components for electrification, brakes, chassis and suspension, steering, airbags, lighting, and automotive electronics. It operates its R&D headquarters in Korea, with four technology centers in the United States, Germany, China, and India. For more information, please visit the website at http://www.mobis.com.

Media Contact 
Choon Kee Hwang: ckhwang@mobis.com
Jihyun Han: jihyun.han@mobis.com

Phase 2b/3 Alzheimer’s trial enrolment passes 50% – twenty US trial sites continuing to recruit participants

SYDNEY, Aug. 27, 2025 /PRNewswire/ — Actinogen Medical Limited (ASX: ACW) announces that a recent trial designed to confirm therapeutic blood levels of the intended commercial tablet formulation of Xanamem®, given both with and without food, demonstrated the expected blood levels or “exposure”, comparable with prior studies of a capsule formulation. This indicates that 10 mg once daily remains the target therapeutic dose for the clinical program.

The trial was conducted at the CMAX clinical research center in Adelaide, Australia where 16 individuals were studied on two occasions, one week apart. Each received a 10 mg tablet of Xanamem once while fasting and once after a high fat meal. Blood levels of Xanamem were then measured frequently over the ensuing 48 hours.

Key results include the median time to maximum blood concentration of 4 to 6 hours (4 hours fasted, 6 hours after a high fat meal), and very similar Xanamem exposures (area under the concentration-time curve) and elimination half-life of 15 hours in both fed and fasted situations.

Professor Paul Rolan, Actinogen’s Clinical Pharmacologist commented:

“This trial confirmed that the intended commercial formulation of Xanamem produces consistent and therapeutic levels in the blood that are similar when given with or without food, giving full flexibility for dosing. These data support the use of the 10 mg daily dose irrespective of food intake in the ongoing XanaMIA phase 2b/3 trial in people with mild to moderate Alzheimer’s disease. Xanamem is a remarkable oral therapeutic with low drug interaction potential, and a 15-hour half-life suitable for once daily dosing in an elderly population.”

XanaMIA phase 2b/3 Alzheimer’s disease trial progress

Enrolment in the pivotal XanaMIA phase 2b/3 Alzheimer’s disease (AD) clinical trial has passed 55% as at the end of July 2025.

The trial is enrolling 220 participants with elevated levels of the blood biomarker pTau181, designed to identify participants with biomarker-positive AD whose disease is likely to progress during the 36-week treatment period of the trial, and therefore augment the ability to detect a Xanamem (emestedastat) treatment benefit. The primary endpoint of the trial is the Clinical Dementia Rating – Sum of Boxes scale, universally included in contemporary AD trials. Other measures include the effects of Xanamem on clinical endpoints of cognition and functional ability.

A planned safety and efficacy futility interim analysis of all available data by an independent Data Monitoring Committee will occur in January 2026.

Final results for the full enrolment of 220 participants are expected in Q4 2026.

How to enrol in the XanaMIA phase 2b/3 Alzheimer’s disease trial in the US

Actinogen is encouraging individuals and their loved ones affected by Alzheimer’s disease to take part in a groundbreaking clinical trial that could transform the way we treat this devastating condition.

The trial is enrolling people diagnosed with mild to moderate Alzheimer’s disease, offering them a chance to participate in cutting-edge research aimed at stabilizing the cognitive and functional decline of Alzheimer’s.

Xanamem inhibits the production of the “stress hormone”, cortisol, in key areas of the brain that are linked to memory and critical thinking. Watch a two-minute explainer video on how Xanamem works here.

The trial involves taking a single pill once a day of Xanamem or matching placebo (“sugar pill”) and a series of clinic visits for the assessment of Alzheimer’s progress. It does not involve frequent brain scans or complicated procedures such as lumbar puncture.

All participants at the end of the XanaMIA trial are eligible for Actinogen’s open-label extension trial of active Xanamem for up to 24 months. This extension trial will open to completed XanaMIA participants in early 2026.

Who can join?

• Individuals aged 50 or older with a diagnosis of mild to moderate Alzheimer’s disease
• Participants with a study partner willing to attend clinic visits
• Additional eligibility criteria apply

You can find out more information in these ways:

• Check eligibility: https://app.clinials.io/en-US/alzheimers
• Email Actinogen’s clinical trials team: clinicaltrials@actinogen.com.au
• Trial website link: https://actinogen.com.au/xanamia-phase-2b-trial/

About Actinogen Medical

Actinogen Medical (ACW) is an ASX-listed, biotechnology company in the late clinical stages of development for Xanamem® (emestedastat), its novel oral therapy for Alzheimer’s disease and depression. The Company is based in Sydney, Australia with operations and clinical trials in Australia and the US. Xanamem, has been studied in eight clinical trials with more than 400 people treated to date and has a promising safety and efficacy profile. ACW’s ongoing clinical trial, XanaMIA, is a phase 2b/3 trial of 220 participants with mild to moderate Alzheimer’s disease (AD) and is currently enrolling in Australia and the US. To find out more about the trial click here.

About Xanamem (emestedastat)

Xanamem’s novel mechanism of action is to control the level of cortisol in the important areas of the brain through the inhibition of the cortisol synthesis enzyme, 11β-HSD1, without blocking normal production of cortisol by the adrenal glands. Xanamem is a first-in-class, once-a-day pill designed to deliver high levels of brain cortisol control in regions where 11β-HSD1 is highly expressed such as the hippocampus. Chronically elevated cortisol is associated with progression in Alzheimer’s Disease and excess cortisol is known to be toxic to brain cells. Elevated cortisol is also associated with depressive symptoms. Xanamem has demonstrated excellent brain target engagement and in human trials has shown potential to slow progression of Alzheimer’s disease and improve depressive symptoms in patients with moderately severe depression. To view Xanamem’s two-minute Mechanism of Action video, click here.

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem® is a trademark of Actinogen Medical.

List of XanaMIA phase 2b/3 trial clinical sites in the US

To check eligibility: https://app.clinials.io/en-US/alzheimers

Disclaimer

This announcement and attachments may contain certain “forward-looking statements” that are not historical facts; are based on subjective estimates, assumptions and qualifications; and relate to circumstances and events that have not taken place and may not take place. Such forward looking statements should be considered “at-risk statements” – not to be relied upon as they are subject to known and unknown risks, uncertainties and other factors (such as significant business, economic and competitive uncertainties / contingencies and regulatory and clinical development risks, future outcomes and uncertainties) that may lead to actual results being materially different from any forward looking statement or the performance expressed or implied by such forward looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Actinogen Medical does not undertake any obligation to revise such statements to reflect events or any change in circumstances arising after the date hereof, or to reflect the occurrence of or non-occurrence of any future events. Past performance is not a reliable indicator of future performance. Actinogen Medical does not make any guarantee, representation or warranty as to the likelihood of achievement or reasonableness of any forward-looking statements and there can be no assurance or guarantee that any forward-looking statements will be realized.

ORLANDO, Fla., Aug. 27, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier technology solutions provider for the leisure, entertainment, attractions and cultural markets globally, is deepening its collaboration with PayPal to deliver trusted, flexible, and guest-friendly payment options. This next-generation integration builds on accesso‘s original PayPal Checkout support and introduces a significantly more powerful, flexible, and conversion-optimized payment experience for venues worldwide.

Since the initial integration of PayPal’s digital payments into accesso’s solutions, accesso clients have benefited from a checkout experience that is fast, secure and optimized for conversion. The new implementation delivers a comprehensive suite of capabilities that allows guests to complete transactions using Venmo, Pay Later, PayPal Credit, Pay in 3 (UK) and card-based payments; all within a streamlined, mobile-friendly checkout interface.

“Consumer expectations are evolving rapidly, and it’s vital we empower our clients with the trusted, flexible payment options guests expect,” said Michael Wiggins, Senior Director, Global Services at accesso. “This expanded collaboration with PayPal broadens our wallet offering to provide an even stronger commerce platform built for growth. It’s about giving guests more ways to pay — and giving our clients more ways to convert.”

Available to accesso clients through accessoPay 3.0 the PayPal integration includes:

PayPal Checkout: Uninterrupted on-site checkout experience with trusted security.

Venmo: Mobile-first payment popular with Millennial and Gen Z guests.

Pay Later & PayPal Credit: Flexible financing options that give guests choice over how they pay.

Guest Checkout for card experience: Gives buyers the option to check out using a debit or credit card, without the need for a PayPal account login.

Pay in 3 (UK): Interest-free installment payments available to eligible guests in the United Kingdom.

This collaboration is helping venues around the world meet growing consumer demand for speed, flexibility, and choice at checkout.

PayPal will be a Gold Sponsor at the upcoming accesso Client Conference 2025 in Orlando, Florida where attendees can learn more about their offerings.  

About accesso Technology Group plc

accesso is the leading global provider of patented and award-winning technology solutions that redefine the guest experience, drive increased revenue, streamline operations, and support data-driven business decisions for leisure and entertainment operators. Currently serving over 1,200 venues worldwide, accesso invests heavily in research and development to provide venues with technology that empowers unforgettable guest experiences. Staffed by a team of attractions, cultural venue, and ski industry veterans, accesso partners with venues to maximize guest engagement and revenue through intuitive ticketing, point-of-sale, virtual queuing, distribution, and experience management technologies.

accesso is a public company, listed on AIM: a market operated by the London Stock Exchange. Learn more at accesso.com or follow accesso on X (Twitter), LinkedIn and Facebook.

RIYADH, Saudi Arabia, Aug. 27, 2025 /PRNewswire/ — Kaiyi Automobile has successfully completed an intensive high-temperature endurance test spanning two to three months in Saudi Arabia, accumulating over 50,000 kilometers across diverse terrains. The test route included Jeddah, Riyadh, Dammam, Taif, and Abha, covering coastal, desert, and mountainous regions. By subjecting its vehicles to the Red Sea’s humid coastal winds, arid desert expanses, and winding highland roads, Kaiyi thoroughly simulated the most challenging driving conditions typical of the Middle East.

Amid extreme heat, sand, and dust, Kaiyi’s key models—the X7, X3, X3 Pro, and E5—each completed the trials successfully. Each vehicle demonstrated consistent performance in thermal management, durability, safety, and comfort, affirming the brand’s engineering prowess and its commitment to producing high-quality, globally adaptable vehicles.

Throughout the testing program, all core models underwent rigorous assessments such as prolonged solar exposure, urban commuting, and sustained mountain driving. These evaluations confirmed the vehicles’ stability in power output, heat insulation, and ride comfort. For example, after 240 minutes of direct exposure in the desert, the cabin temperature exceeded 75°C with 42% humidity. Within three minutes of activating the air conditioning, the outlet temperature dropped to 19°C, while the cabin cooled to 36°C with humidity reduced to 30%. Within five minutes, the outlet temperature fell further to 16°C and the cabin to 33°C. After 25 minutes, the outlet temperature stabilized at 10°C and the cabin reached a comfortable 23°C with humidity holding at 30%—well within the ideal range for human comfort.

As a flagship SUV, the X7—equipped with advanced thermal management and superior cabin insulation—delivered faster cooling rates and more stable temperature control under identical conditions. It combined rugged all-terrain capability with refined comfort, providing passengers a luxurious and assured driving experience.

Beyond climate performance, Kaiyi’s vehicles also underwent stringent validation of intelligent cabin functions, structural integrity, and reliability during prolonged operation. Features such as voice recognition, panoramic imaging, and driver-assistance systems performed flawlessly despite the extreme heat. No thermal degradation or performance deviation was detected in the chassis or electronic control systems, underscoring the vehicles’ overall consistency and reliability.

These outcomes highlight Kaiyi’s profound engineering expertise and its capability to deliver finely calibrated vehicles tailored to global markets.

The successful completion of the high-temperature endurance tests not showcases Kaiyi’s technical maturity but also represents a critical milestone in the brand’s global strategy. Bolstered by a solid engineering foundation and expanding international presence, Kaiyi is accelerating its “go global” campaign. With the Middle East as a strategic hub, the brand will deepen regional cooperation, enhance localized services, and refine customized product offerings—further strengthening its worldwide influence.

At a time when international standards grow increasingly stringent, Kaiyi has demonstrated through action that its products are engineered to excel worldwide—backed by the vision, confidence, and adaptability to succeed on the global stage.

New safety initiative strengthens Thailand‘s position as a trusted and welcoming destination for international visitors

BANGKOK, Aug. 27, 2025 /PRNewswire/ — The Tourism Authority of Thailand (TAT), under the Ministry of Tourism and Sports, today officially launched the “Trusted Thailand” Stamp to reinforce international confidence and enhance the kingdom’s image as a safe, reliable and welcoming destination. The initiative assures travellers of peace of mind when choosing Thailand, while recognising operators that meet the highest safety standards.

Mr. Jakkaphon Tangsutthitham, Vice Minister of Tourism and Sports, said the Thai Government recognises that safety is the foundation of sustainable tourism and remains the first priority in policy. “China is a key source market, and it is crucial that we preserve trust among Chinese visitors. This launch reflects an invitation to all tourism operators, partnered agencies and stakeholders to work together in advancing Thailand’s tourism towards safe, secure and sustainable growth, ensuring Thailand remains one of the world’s top destinations of choice.

“The government has continuously paired safety measures with tourism promotion, including upgrading the standards of attractions, coordinating with security agencies, delivering accurate communication, and facilitating visitors in all dimensions. These efforts signal steady recovery and are the result of collective cooperation in building trust,” Mr. Jakkaphon added.

Thailand continues to attract travellers worldwide with its diverse tourism assets, warm hospitality and unique cultural identity. Yet, in today’s travel environment, safety has become a decisive factor, especially among families, female travellers, independent tourists, and quality visitors from key markets such as China, South Korea, Japan, the US, the UK, and Europe.

Online platforms and social media significantly shape a destination’s image, and negative reports can impact confidence on a wide scale. Recognising this, TAT has prioritised the development of a robust initiative that demonstrates Thailand’s readiness to be a safe, trustworthy, and friendly destination in both systemic and symbolic ways.

Ms. Thapanee Kiatphaibool, TAT Governor, said “The Trusted Thailand stamp is a practical mechanism to restore traveller confidence while laying the foundation for Thailand’s tourism industry to meet international safety standards. More than a symbol, it represents our commitment to making Thailand a destination where every visitor feels secure and truly welcome.”

Under this initiative, tourism operators will be assessed to receive the “Trusted Thailand“ stamp, serving as a practical symbol of assurance to help visitors make informed decisions. The assessment covers four key areas: general safety measures at tourism sites such as CCTV installation, emergency response systems, controlled access and disaster preparedness; secure financial transactions with recognised global platforms and transparent practices (such as Alipay and WeChat Pay); foreign language communication and professional visitor care, particularly in emergencies; and safe access and mobility, including clear signposting, transport connections and information points.

Beyond certification, the project also features supporting activities to strengthen confidence across the sector. These include a public forum with agencies such as the Department of Provincial Administration, Department of Tourism, Tourist Police Bureau and Department of Land Transport to discuss integrated safety management; workshops on passenger transport safety with demonstrations of emergency procedures; and targeted campaigns to rebuild trust ahead of the high season in both short-haul markets like China and long-haul markets in Europe and the Americas.

The project targets a strong focus on accommodations, restaurants, attractions, recreational venues and shopping centres, which are key points of interest for Chinese travellers.

A dedicated mini–site will be launched in September 2025, providing a self-assessment platform for operators and a directory of certified businesses accessible to visitors.

Initially, the Thailand Safe Travel Stamp project is scheduled to launch nationwide in October 2025, with implementation across the country. It will place strong emphasis on international publicity through multilingual content, targeted digital campaigns, and collaborations with key opinion leaders and influencers from priority markets. These efforts aim to project a refreshed image of Thailand as a modern, stable, and safe destination, under the concept “Travel Thailand with Confidence Every Step of the Way.”

BEIJING, Aug. 27, 2025 /PRNewswire/ — A report from China Daily

The Ningxia Hui autonomous region is ready for the seventh China-Arab States Expo, to be held in its capital city Yinchuan from Thursday to Sunday. The event now promotes not only cooperation between Ningxia and Arab countries but partnership with those involved in the Belt and Road Initiative.

With the theme of “Innovation, Green Development and Prosperity”, this year’s expo will feature BRI-related trade and investment promotion activities, two institutional events, six major exhibition zones, eight subevents and other economic and trade networking activities.

Among BRI-related activities will be the Promotion Event on Overseas Industrial Parks and Infrastructure Investment and Construction in BRI Countries, the Multinational Economic and Trade Cooperation Meeting in Ningxia, and the China-Arab States Green and Low-Carbon Products Matchmaking and Exchange Event.

The United Arab Emirates is the guest country of honor, which features a UAE national pavilion and is set to host a promotion conference on China-UAE economic and trade cooperation along with some visits. The Xinjiang Uygur autonomous region is invited as the theme province, with Xinjiang pavilion exhibition and display activities, a Xinjiang-Ningxia investment promotion and industrial cooperation matchmaking meeting, and inspection and observation tours.

The six major exhibition zones are for BRI-related countries, regional economic cooperation, central State-owned enterprises, clean energy, the digital economy and specialty commodities.

The digital economy exhibition zone comprises displays of artificial intelligence, gaming industries, smart meteorology and cross-border e-commerce, with the AI and gaming sector exhibition areas being new.

In the clean energy display area, the “green electricity application zone” is to be set up for the first time and many leading companies will bring cutting-edge technologies and solutions. State Grid Ningxia Electric Power will showcase a model for the local consumption of new energy power.

The cross-border e-commerce exhibition has invited four leading platforms in the field — Amazon, Alibaba.com, Wayfair and Noon — and 56 other companies. It will focus on public experience and offer online and offline participation channels.

The eight subevents will focus on matchmaking and exchange of China-Arab states business community, technology transfer and innovation cooperation, modern agriculture, water resources, health, China-Arab tour operators, high-quality meteorological development, and China-Arab standardization and intellectual property exchange.

Among other activities at the expo are the “Silk Road E-commerce” Cooperation and Innovation Development Conference, BRI gourmet culture display and sale, exhibition cooperation and resource matchmaking, and new product launch events.

The China-Arab States Expo is jointly hosted by the Ministry of Commerce, the China Council for the Promotion of International Trade and the Ningxia government. Its predecessor was the China (Ningxia) International Investment and Trade Fair and the China-Arab States Economic and Trade Forum, which was held annually from 2010 to 2012. Approved by the State Council, the forum was renamed the China-Arab States Expo in 2012.Since 2013, it has been held biennially.

The six sessions of the expo have attracted the participation of 112 countries and regions, more than 400 important Chinese and foreign political figures, and over 7,500 domestic and foreign enterprises.

In terms of mechanism building, the expo adheres to a distinctive model of organization and the mechanism of guest countries and theme provinces. It has invited six Arab countries — the UAE, Kuwait, Jordan, Egypt, Morocco and Saudi Arabia — as national guests of honor, and six Chinese provincial-level regions as theme provinces.

The expo focuses on practical economic and trade cooperation, aligning with the development strategies of China and Arab countries, and sets up diverse activities mainly based on trade in goods, services and technology. It has continuously fostered cooperation in trade and investment, modern agriculture, science and technology, green energy, digital economy, and healthcare. It also showcased high-quality products and the latest technologies needed by China and Arab countries.

In terms of outcomes, a total of 1,616 trade and investment cooperation projects have been signed, covering key China-Arab cooperation in areas such as infrastructure construction, capacity cooperation, high technology, healthcare and modern agriculture.

Several China-Arab partnership results have been released, including a report on the development process of China-Arab economic and trade relations. Some China-Arab bilateral and multilateral cooperation institutions — such as the China-Arab States Technology Transfer Center, a China-Arab commercial mediation center and a China-Arab agricultural technology transfer center — have been established in Ningxia.

In recent years, China-Arab economic and trade cooperation has made significant achievements. In terms of bilateral trade, China has signed BRI cooperation documents with 22 Arab countries and the League of Arab States. China has maintained its position as the largest trading partner of Arab countries for several years. Products such as Saudi shrimp, Tunisian olive oil, Sudanese sesame and Egyptian oranges are increasingly being favored by Chinese consumers.

For two-way investment, Chinese enterprises have established several industry parks in countries like Egypt, the UAE and Saudi Arabia, implementing a range of productive projects in metal smelting, building materials manufacturing, cotton spinning and aquaculture, thus aiding in the economic diversification of Arab countries.

Meanwhile, Arab sovereign wealth funds and enterprises have invested in China’s petrochemical, new energy and technology sectors, achieving mutual benefits.

Regarding infrastructure cooperation, Chinese companies have participated in engineering projects in Arab countries, expanding from traditional housing and road and bridge construction to broader fields such as high-speed rail, power stations, oil pipelines, communications and ports, with higher technological and equipment levels. Bilateral cooperation projects included the construction of an important highway in Algeria, a large stadium in Qatar and a photovoltaic power station in Saudi Arabia.

In emerging fields, China and Arab countries are exploring cooperation potential in cutting-edge areas such as e-commerce, cloud computing, AI, low-carbon development and financial technology. Chinese companies have established 5G commercial networks in Arab countries, enhancing local informatization levels. At the same time, Chinese e-commerce platforms are gradually entering markets in countries like Morocco, Saudi Arabia and Egypt, supporting the daily lives of Arab people.